Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients

摘要

BackgroundClinical data identified an association between the use of HMG-CoA reductase inhibitors (statins) and incident diabetes in patients with underlying diabetes risk factors such as obesity, hypertension and dyslipidemia. The molecular mechanisms however are unknown.